0001250853-18-000121.txt : 20180906
0001250853-18-000121.hdr.sgml : 20180906
20180906200712
ACCESSION NUMBER: 0001250853-18-000121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180904
FILED AS OF DATE: 20180906
DATE AS OF CHANGE: 20180906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chin Richard
CENTRAL INDEX KEY: 0001337252
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36225
FILM NUMBER: 181058732
MAIL ADDRESS:
STREET 1: C/O OXIGENE, INC.
STREET 2: 230 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kindred Biosciences, Inc.
CENTRAL INDEX KEY: 0001561743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461160142
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-701-7901
MAIL ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-09-04
0
0001561743
Kindred Biosciences, Inc.
KIN
0001337252
Chin Richard
C/O KINDRED BIOSCIENCES, INC.
1555 BAYSHORE HIGHWAY, SUITE 200
BURLINGGAME
CA
94010
1
1
1
0
PRESIDENT AND CEO
COMMON STOCK
2018-09-04
4
S
0
32400
14.81
D
2073671
D
COMMON STOCK
2018-09-05
4
S
0
7600
14.69
D
2066071
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.75 to $14.95, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.55 to $14.80, inclusive.
/S/ Dietrick L. Miller, Attorney-in-Fact
2018-09-06